USPTO trademark

VELOXIS

RegisteredUSPTOWord markClass 5Class 41Class 42Class 44

"VELOXIS" is a word mark owned by Veloxis Pharmaceuticals, Inc., filed at the USPTO on January 13, 2023. It is registered and covers classes 5, 41, 42 and 44.

Official USPTO record
VELOXIS trademark as filed
As filed with the USPTO
Status
Registered
Since December 9, 2025
Filed
January 13, 2023
Registered
December 9, 2025
Priority date
January 11, 2023
Claimed from European Union
Application no.
97753205
Registration no.
8055155
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns VELOXIS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services VELOXIS is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplant patients; pharmaceutical preparations and drug delivery systems, pharmaceutical modified release systems, and pharmaceutical controlled release systems, comprised of tablets, granules, pills, sachets, powders, capsules, solutions or fluids, all of the above for use in the treatment of physical disorders, emergencies and traumas, burns, diseases of the heart and blood vessels, neurological diseases, and cancer

  • Education and training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical and pharmaceutical fields

  • Scientific and technological services, namely, scientific research, analysis and testing in the field of medical science, pharmacology, biotechnology and bacteriological areas and providing consultation and information relating thereto; design of drug delivery systems for medical use; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries

  • Medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. On hold - electronic record review required
  7. On hold - electronic record review required
  8. Use affidavit failed formalities
  9. Notice of allowance cancelled
  10. Noa e-mailed - sou required from applicant

10 earlier steps on the official record.

FAQ

About VELOXIS

Who owns the trademark "VELOXIS"?

The USPTO trademark "VELOXIS" (application 97753205) is owned by Veloxis Pharmaceuticals, Inc.

What is the status of "VELOXIS"?

Its status at the USPTO is: registered.

When was "VELOXIS" registered?

It was registered on December 9, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull VELOXIS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2b48-6df2-72be-8337-f67c3615aaf3
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b48-6df2-72be-8337-f67c3615aaf3",
  "object": "trademark",
  "mark_text": "VELOXIS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97753205",
  "filing_date": "2023-01-13",
  "nice_classes": [
    5,
    41,
    42,
    44
  ],
  "owners": [
    {
      "name": "Veloxis Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb70d-9d29-7010-afb1-780b1aaac666"
    }
  ]
}